Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Size By Type (Analgesics, NSAIDs), By Application (Hospital Pharmacy, Online Drug Stores), By Geographic Scope And Forecast

Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Size And Forecast

Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e., 2022 to 2030.

The high growth of the Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market is due to an increase in the number of cancer cases, as well as an increase in patient and healthcare provider awareness of the hand-foot syndrome. Other factors driving the growth of this market include the availability of new treatments and increased government support for R&D activities. The Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Definition

Acral erythema, also known as palmar-plantar erythrodysesthesia or hand-foot syndrome, is characterized by swelling, redness, paraesthesia (numbness), and desquamation (skin peeling) of the palms, soles, and, in rare cases, the knees and elbows. Acryl erythema is a common adverse drug reaction that occurs after several months of treatment with chemotherapeutic agents, gemcitabine, and fluorouracil being the most common culprits. Chemotherapy-induced acryl erythema is a dose-dependent condition that can be reversed by discontinuing chemotherapy or reducing the dose.

To relieve pain and edema caused by chemotherapy, analgesics and antihistaminic drugs are used to treat acryl erythema. The increased use of chemotherapeutic agents as cancer incidence rises is the primary growth driver in the global chemotherapy-induced acral erythema treatment market. Furthermore, lifestyle changes and an increase in the number of smokers are some secondary factors responsible for the rise in the Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market.

Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Overview

Data from two large phases III studies were used to develop a longitudinal model to predict hand-and-foot syndrome (HFS) dynamics in capecitabine patients. The capecitabine arms included a large number of patients; some were chosen at random to build the model, while others were assigned to model validation. The proportional odds model, a sigmoidal maximum effect model driven by capecitabine accumulation as estimated by a kinetic-pharmacodynamic model, and a Markov process were used to generate a risk score for developing HFS. The higher the risk of HFS, the lower the calculated creatinine clearance value at inclusion. Visual and statistical predictive checks were used to validate the model.

Furthermore, the treatment of hand-foot syndrome is primarily symptomatic. If there is swelling or inflammation, topical steroid creams may be prescribed, or cancer treatment may be delayed until the symptoms improve. To manage this side effect, the chemotherapy dose is sometimes adjusted. In addition, moisturizers are advised for dry skin. Medicated creams, such as urea cream, can sometimes help get rid of rough skin. Celebrex is sometimes used to treat pain, but it is not commonly prescribed. They should refrain from picking at dry skin, breaking blisters, or immersing their hands in hot water. When moisturizing, avoid vigorously rubbing the creams in, and is expected the growth of the Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market even further.

Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment MarketSegmentation Analysis

The Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market is segmented on the basis of Type, Application, And Geography.

Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market, By Type

• Analgesics• Anti-Inflationary & Anti-Edematous Agents• NSAIDs• Others

Based on Type, The market is segmented into Analgesics, Anti-Inflationary & Anti-Edematous Agents, NSAIDs, and Others. Anti-Inflationary & Anti-Edematous Agents medications work to reduce swelling and inflammation. They are most commonly used to treat arthritis, bursitis, and tendinitis. These medications could be taken orally or topically. Ibuprofen, naproxen, and celecoxib are common anti-inflammatory and anti-edematous agents and increasing the market growth of the Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market globally.

Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market, By Application

• Pharmacy & Drugstores• Hospital Pharmacy• Online Drug Stores• Others

Based on Application, The market is segmented into Pharmacy & Drugstores, Hospital Pharmacy, Online Drug Stores, and Others. Treatment for Chemotherapy-Induced Acral Erythema (Hand-Foot Syndrome) is available in pharmacies and drugstores for the treatment of chemotherapy-induced acral erythema, also known as hand-foot syndrome. This is a condition that causes hand and foot redness, swelling, and pain. Symptoms typically appear during or after chemotherapy treatments. Chemotherapy-Induced Acral Erythema (Hand-Foot Syndrome) Treatment can help alleviate the symptoms of this condition, which is driving the market growth increasing the Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market globally.

Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Geography, The Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market is segmented into North America, Europe, Asia Pacific, and the Rest of the world. Because of the high prevalence of cancer and raising awareness about early detection and treatment of cancer, North America is expected to dominate the Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market, thereby it will be driving the growth of the region’s Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market in the coming years.

Key Players

The “Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Taro, Oceanside Pharmaceuticals, Pfizer, Novartis, A-S Medication Solutions, Preferred Pharmaceuticals, Syntex Pharmaceuticals, Valeant Canada, Technilab Pharma, Allergan.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In Feb 2022, Taro Pharmaceutical Industries Ltd. (NYSETARO) (“Taro”) recently announced that it had completed its acquisition of Alchemee, formerly The Proactiv Company (TPC), from Galderma. The acquisition includes Alchemee’s global operations and assets.

• In May 2022, Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. recently announced that they have reached a definitive agreement in which Pfizer will acquire Biohaven, the maker of an innovative dual-acting migraine therapy approved for both acute treatment and episodic migraine prevention in adults.

• In Dec 2021, Novartis will acquire Gyroscope Therapeutics, which will add a one-time gene therapy that has the potential to transform care for geographic atrophy, a leading cause of blindness.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.